Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

73 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community.
Mirza MA, Larsson A, Lind L, Larsson TE. Mirza MA, et al. Among authors: larsson a, larsson te. Atherosclerosis. 2009 Aug;205(2):385-90. doi: 10.1016/j.atherosclerosis.2009.01.001. Epub 2009 Jan 9. Atherosclerosis. 2009. PMID: 19181315
Associations of Fibroblast Growth Factor 23 with Markers of Inflammation and Leukocyte Transmigration in Chronic Kidney Disease.
Wallquist C, Mansouri L, Norrbäck M, Hylander B, Jacobson SH, Larsson TE, Lundahl J. Wallquist C, et al. Among authors: larsson te. Nephron. 2018;138(4):287-295. doi: 10.1159/000485472. Epub 2018 Jan 4. Nephron. 2018. PMID: 29301137
New insights into the FGF23-Klotho axis.
Olauson H, Vervloet MG, Cozzolino M, Massy ZA, Ureña Torres P, Larsson TE. Olauson H, et al. Among authors: larsson te. Semin Nephrol. 2014 Nov;34(6):586-97. doi: 10.1016/j.semnephrol.2014.09.005. Semin Nephrol. 2014. PMID: 25498378 Review.
The role of klotho on vascular calcification and endothelial function in chronic kidney disease.
Vervloet MG, Adema AY, Larsson TE, Massy ZA. Vervloet MG, et al. Among authors: larsson te. Semin Nephrol. 2014 Nov;34(6):578-85. doi: 10.1016/j.semnephrol.2014.09.003. Semin Nephrol. 2014. PMID: 25498377 Review.
Arterial klotho expression and FGF23 effects on vascular calcification and function.
Lindberg K, Olauson H, Amin R, Ponnusamy A, Goetz R, Taylor RF, Mohammadi M, Canfield A, Kublickiene K, Larsson TE. Lindberg K, et al. Among authors: larsson te. PLoS One. 2013;8(4):e60658. doi: 10.1371/journal.pone.0060658. Epub 2013 Apr 5. PLoS One. 2013. PMID: 23577141 Free PMC article.
Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?
Olauson H, Qureshi AR, Miyamoto T, Barany P, Heimburger O, Lindholm B, Stenvinkel P, Larsson TE. Olauson H, et al. Among authors: larsson te. Nephrol Dial Transplant. 2010 Sep;25(9):3033-8. doi: 10.1093/ndt/gfq191. Epub 2010 Apr 5. Nephrol Dial Transplant. 2010. PMID: 20368304
Fibroblast growth factor 23, mineral metabolism and mortality among elderly men (Swedish MrOs).
Westerberg PA, Tivesten Å, Karlsson MK, Mellström D, Orwoll E, Ohlsson C, Larsson TE, Linde T, Ljunggren Ö. Westerberg PA, et al. Among authors: larsson te. BMC Nephrol. 2013 Apr 15;14:85. doi: 10.1186/1471-2369-14-85. BMC Nephrol. 2013. PMID: 23587028 Free PMC article.
Serum FGF23 and risk of cardiovascular events in relation to mineral metabolism and cardiovascular pathology.
Ärnlöv J, Carlsson AC, Sundström J, Ingelsson E, Larsson A, Lind L, Larsson TE. Ärnlöv J, et al. Among authors: larsson a, larsson te. Clin J Am Soc Nephrol. 2013 May;8(5):781-6. doi: 10.2215/CJN.09570912. Epub 2013 Jan 18. Clin J Am Soc Nephrol. 2013. PMID: 23335040 Free PMC article.
Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals.
Mirza MA, Alsiö J, Hammarstedt A, Erben RG, Michaëlsson K, Tivesten A, Marsell R, Orwoll E, Karlsson MK, Ljunggren O, Mellström D, Lind L, Ohlsson C, Larsson TE. Mirza MA, et al. Among authors: larsson te. Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):219-27. doi: 10.1161/ATVBAHA.110.214619. Epub 2010 Oct 21. Arterioscler Thromb Vasc Biol. 2011. PMID: 20966399
Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men.
Mirza MA, Karlsson MK, Mellström D, Orwoll E, Ohlsson C, Ljunggren O, Larsson TE. Mirza MA, et al. Among authors: larsson te. J Bone Miner Res. 2011 Apr;26(4):857-64. doi: 10.1002/jbmr.263. J Bone Miner Res. 2011. PMID: 20928885
73 results
Jump to page
Feedback